Monographs: Dosage forms: Specific monographs: Phenoxymethylpenicillin potassium tablets (Phenoxymethylpenicillini kalici compressi)Category. Antibacterial drug. Storage. Phenoxymethylpenicillin potassium tablets should be kept in a tightly closed container. Labelling. The designation on the container indicates the quantity of active ingredient in terms of the equivalent amount of phenoxymethylpenicillin. It also indicates whether the tablets are to be chewed before swallowing. Expiry date. Additional information. Strength in the current WHO Model list of essential medicines: 250 mg. Requirements Comply with the monograph for "Tablets". Phenoxymethylpenicillin potassium tablets contain not less than 90.0% and not more than 110.0% of the amount of C16H18N2O5S stated on the label. Identity tests
Loss on drying. Dry a quantity of the powdered tablets equivalent to 0.1 g of Phenoxymethylpenicillin potassium under reduced pressure (not exceeding 0.6 kPa or 5 mm of mercury) at 60 °C for 3 hours; it loses not more than 15 mg/g. Phenoxyacetic acid. Carry out the test as described under 1.14.1 Chromatography, Thin-layer chromatography, using silica gel R1 as the coating substance and a mixture of 90 volumes of diisopropyl ether R, 7 volumes of anhydrous formic acid R, and 1 volume of water as the mobile phase. Apply separately to the plate 10 μl of each of the following two solutions. For solution (A) shake a quantity of the powdered tablets equivalent to 0.25 g of Phenoxymethylpenicillin potassium with 25 mL of a mixture of equal volumes of methanol R and water, filter, and use the clear filtrate. For solution (B) dissolve 10 mg of phenoxyacetic acid R in the same mixture of solvents. After removing the plate from the chromatographic chamber, allow it to dry in a current of warm air and spray with a mixture of 0.15 g of potassium permanganate R dissolved in 100 mL of sulfuric acid (0.5 mol/l) VS. Examine the chromatogram in daylight. Any spot corresponding to phenoxyacetic acid obtained with solution A is not more intense than that obtained with solution B. Assay. Weigh and powder 20 tablets. Shake a quantity of the powder equivalent to about 125 mg of Phenoxymethylpenicillin potassium, accurately weighed, with 300 mL of water for 30 minutes, add sufficient water to produce 500 mL, dilute 25 mL to 100 mL with water, and filter. Transfer two 2-mL aliquots of the filtrate into separate stoppered tubes. To one tube add 10 mL of imidazole/mercuric chloride TS, mix, stopper the tube, and place it in a water-bath at 60 °C for exactly 25 minutes. Cool the tube rapidly to 20 °C (solution A). To the second tube add 10 mL of water and mix (solution B). Without delay measure the absorbance of a 1-cm layer at the maximum at about 325 nm against a solvent cell containing a mixture of 2 mL of water and 10 mL of imidazole/mercuric chloride TS for solution A and water for solution B. From the difference between the absorbance of solution A and that of solution B, calculate the amount of C16H18N2O5S in the sample being examined by comparison with phenoxymethylpenicillin potassium RS. In an adequately calibrated spectrophotometer the absorbance of the reference solution should be 0.63 ± 0.03. Dissolution/Disintegration. For tablets other than those that are intended to be chewed before being swallowed: • Either test A or test B may be applied
|